AI assistant
Shattuck Labs, Inc. — Director's Dealing 2025
Sep 2, 2025
34607_dirs_2025-09-02_0144aeb3-09a0-48b1-9d6b-6bdf5d9c8dec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Shattuck Labs, Inc. (STTK)
CIK: 0001680367
Period of Report: 2025-08-28
Reporting Person: Ashiya Mona (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-28 | Stock Option (Right to Buy) | $0.99 | A | 66300 | Acquired | 2035-08-28 | Common Stock (66300) | Direct |
Footnotes
F1: This option represents the right to purchase a total of 66,300 shares of the Issuer's common stock, and vests in three equal annual installments on each of the first three anniversaries of August 28, 2025, subject to the Reporting Person's continued service to the Issuer.
F2: Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP IX LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments IX, LP.